← All candidates
110 insider filings on record.
110 filings on record.
BLFSBIOLIFE SOLUTIONS INC
NasdaqCM · Healthcare · $1.77B
$36.11
-0.77% · Sep 16
110 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 40 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what BLFS ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.77B
Float
42.8M
88% public
Short % float
Pro
Price / profit
36.1
Price / future profit
109.4
Price / sales
16.6
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
105 more transactions on Pro →Context
Wall St
$32.11 avg target
-11.1% vs today · 9 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$0.04 act+$0.03
Q4 '25$0.04 act+$0.03
Q3 '25$0.04 act+$0.04
Q2 '25$0.01 act+$0.02
Coverage
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?Insider Monkey · 06-18BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair ValueSimply Wall St. · 06-04A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term MomentumSimply Wall St. · 05-11BioLife (BLFS) Q1 2026 Earnings TranscriptMotley Fool · 05-08
The file stays open
110 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice